Greek study tracks Real-World use of Potassium-Lowering drug in kidney and heart patients

NCT ID NCT06185660

Completed Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jan 07, 2026 · Last updated May 23, 2026 · Updated 22 times

Summary

This study looked at 125 adults in Greece with high potassium levels who also had chronic kidney disease (some on dialysis) or heart failure. Researchers observed how doctors used the drug sodium zirconium cyclosilicate in everyday practice over six months. The goal was to understand patient characteristics and treatment patterns, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERKALAEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Research Site

Alexandroupoli, 68100, Greece
Research Site

Athens, 10676, Greece
Research Site

Athens, 11527, Greece
Research Site

Athens, 12462, Greece
Research Site

Athens, 15123, Greece
Research Site

Heraklion, 71500, Greece
Research Site

Larissa, 41110, Greece
Research Site

Pátrai, 26504, Greece
Research Site

Thessaloniki, 54636, Greece
Research Site

Thessaloniki, 57010, Greece

Conditions

Explore the condition pages connected to this study.

HYPERKALAEMIA